Faruqi & Faruqi, LLP Announces Investigation of ATS Corporation

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of ATS Corporation (“ATS” or the “Company”) (NYSE AMEX: ATSC) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Salient Federal Solutions, Inc., in an all-cash deal valued at about $77 million. Under the terms of the proposed transaction, ATS stockholders will receive $3.20 in cash for each share of ATS common stock they own. As recently as February 2, 2012, ATS stock traded at $3.33 per share – higher than the deal price. The proposed transaction is structured as a tender offer and may be effectuated without a shareholder vote.

Request more information now by clicking here: www.faruqilaw.com/ATSC

Whether ATS Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether the proposed transaction undervalues ATS shares and by how much this proposed transaction undervalues the Company to the detriment of ATS shareholders are the key focus of this investigation.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.

If you own common stock in ATS and wish to obtain additional information, please visit us at www.faruqilaw.com/ATSC or contact Juan E. Monteverde, Esq. either via e-mail at [e-mail] or by telephone at [phone] or [phone].

Attorney Advertising. (C) 2012 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.